Heritable, diet-induced hyperlipidemia in California mice (Peromyscus californicus) is due to increased hepatic secretion of very low density lipoprotein triacylglycerol

Comparative Medicine

Volumn 56, Issue 6, 2006, Pages 468-475

  Krugner Higby, Lisa ^a   Shelness, Gregory S ^b   Holler, Allyson ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; HERITABILITY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPID DIET; LIVER METABOLISM; MATING; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROGENY; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BREEDING; DIETARY FATS; DISEASE MODELS, ANIMAL; FEMALE; HYPERLIPIDEMIAS; LIPASE; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; LIVER; MALE; PEROMYSCUS; TRIGLYCERIDES;

EID: 33845619485     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aitman TJ, Godsland IF, Farren B, Crook D, Wong HJ, Scott J. 1997. Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 17:748-754.
2. Ardern HA, Benson GM, Suckling KE, Caslake MJ, Shepherd J, Packard CJ. 1999. Apolipoprotein B overproduction by the perfused liver of the St. Thomas mixed hyperlipidemic (SMHL) rabbit. J Lipid Res 40:2234-2243.
3. Argyopoulos G, Rankinen T, Neufeld DR, Rice T, Province MA, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. 2002. A polymorphism in the human agouti-related protein is associated with late-onset obesity. J Clin Endocrinol Metabol 87:4198-4202.
4. Ascaso JF, Merchante A, Lorente RI, Real JT, Martinez-Valls J, Carmena R. 1998. A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemia patients. Metabolism 47:508-513.
5. Beaty TH, Prenger VL, Virgil DG, Lewis B, Kwiterovich PO, Bachorik PS. 1992. A genetic model for control of hypertriglyceridemia and apolipoprotein B levels in John Hopkins colony of St Thomas Hospital rabbits. Genetics 132:1095-1104.
6. Buja LM, Clubb FJ Jr., Bilheimer DW, Willerson JT. 1990. Pathobiology of human familial hypercholesterolemia and a related animal model, the Watanabe heritable hyperlipidaemic rabbit. Eur Heart J 11(Suppl E):41-52.
7. Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM. 1994. Expression of human apolipoprotein B and assembly of lipoprotein (a) in transgenic mice. Proc Natl Acad Sci U S A 91:2130-2134.
8. Chen HC, Jensen DR, Myers HM, Eckel RH, Farese RV Jr. 2003. Obesity resistance and enhanced glucose metabolism in mice transplanted with white adipose tissue lacking acyl CoA:diacylglycerol acyltransferase 1. J Clin Invest 111:1715-1722.
9. Chirieac DV, Collins HL, Cianci J, Sparks JD, Sparks CE. 2004. Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats. Physiol Endocrinol Metab 287:E42-E49.
10. Dawson W. 1998. Personal communication.
11. Dolphin PJ, Stewart B, Amy RM, Russell JC. 1987. Serum lipids and lipoproteins in the atherosclerosis prone LA/N corpulent rat. Biochem Biophys Acta 919:140-148.
12. Ehnholm C, Kuusi T. 1986. Preparation, characterization, and measurement of Hepatic Lipase. In Albers JJ, Segrest JP, editors. Methods in enzymology vol. 129. Plasma lipoproteins. Part B. Characterization, cell biology, and metabolism. New York: Academic Press. p 716-738.
13. Escola-Gil JC, Julve J, Marzal-Casacuberta A, Ordonez-Llanos J, Gonzalez-Sastre F, Blanco-Vaca F. 2000. Expression of human apolipoprotein A-II in apolipoprotein E deficient mice induces features of familial combined hyperlipidemia. J Lipid Res 41:1328-1338.
14. Gillian-Daniel DL, Bates PW, Tebon A, Attie AD. 2002. Endoplasmic location of the low density lipoprotein receptor mediates presecretory degradation of apolipoprotein B. Proc Natl Acad Sci U S A 90:4337-4342.
15. Horton JD, Shimano H, Hamilton RL, Brown MS, Goldstein JL. 1999. Disruption of LDL receptor gene in transgenic SREBP-1a mice unmasks hyperlipidemia resulting from production of lipid-rich VLDL. J Clin Invest 103:1067-1076.
16. Hought, D. 2003. Personal communication.
17. Howard BV, Davis MP, Pettitt DJ, Knowler WC, Bennett PH. 1983. Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians. Circulation 68:714-724.
18. Ishibashi S, Goldstein JL, Brown MS, Hetz J, Burns DK. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low-density lipoprotein receptor-negative mice. J Clin Invest 93:1885-1893.
19. Kinnunen PKJ, Thuren T. 1984. Hepatic triacylglyceride lipase. In Bergmeyer HU, Bergmeyer J, Grassl M, editors. Methods of enzymatic analysis, vol IV. Enzymes 2: esterases, glycosidases, lyases, ligases. Deerfield Beach (FL): Verlag Chemie. p 34-42.
20. Krugner-Higby L, Shadoan M, Carlson C, Gendron A, Cofta P, Marler, C, Wagner J. 2000. Type 2 diabetes mellitus, hyperlipidemia, and extremity lesions in California mice (Peromyscus californicus) fed commercial mouse diets. Comp Med 50:412-418.
21. Li X, Catalina F, Grundy SM, Patel S. 1996. Method to measure apolipoprotein B-48 and B-100 secretion rates in an individual mouse: evidence for a very rapid turnover of VLDL and preferential removal of B-48-relative to B-100-containing lipoproteins. J Lipid Res 37:210-220.
22. Masucci-Magoulas L, Goldberg I, Bisgaier CL, Humaira S, Franconce OL, Breslow JL, Tall AR. 1997. A mouse model with features of familial combined hyperlipidemia. Science 275:391-394.
23. McGarry JD, Dobbins, RL. 1999. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42:128-138.
24. Miyazaki M, Kim Y, Gray-Keller MP, Attie A, Ntambi JM. 2000. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for steroyl-CoA desaturase 1. J Biol Chem 39:30,132-130,138.
25. Otway S, Robinson DS. 1967. The use of a nonionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol 190:321-332.
26. Ranheim T, Dumke C, Schueler KL, Cartee GD, Attie A. 1997. Interaction between BTBR and C57BL/6J genomes produces an insulin resistance syndrome in (BTBRXC57BL/6J) F1 mice. Aterioscler Thromb Vasc Biol 17:3286-3293.
27. Russell JC, Ahuja SK, Manickavel V, Rajotte RV, Amy RM. 1987. Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat. Arteriosclerosis 7:620-626.
28. Russell JC, Koeslag DG, Amy RM, Dolphin PJ. 1989. Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis 9:869-876.
29. Shelness GS, Ledford AS. 2005. Evolution and mechanism of apoliprotein B-containing lipoprotein assembly. Curr Opin Lipidol 16:325-332.
30. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. 1996. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98:1575-1584.
31. Vakkilainen J, Porkka KVK, Nuotio I, Pajukanta P, Suurinkeroinen L, Ylitalo K, Viikari JSA, Ehnholm C, Taskinen M-R for the EUFAM Study Group. 1998. Glucose intolerance in familial combined hyperlipidemia. Eur J Clin Invest 28:24-32.
32. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J. 1993. Stable isotopes show a direct relation between VLDL apoB overproduction and plasma triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 13:1110-1118.
33. Williams G, Bing C, Cai XJ, Harrold JA, King PJ, Liu XH. 2001. The hypothalamus and the control of energy homeostasis: different circuits, different purposes. Physiol Behav 74:683-701.
34. Yamazaki T, Sasaki E, Kakinuma C, Yano T, Miura S, Ezaki O. 2005. Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J Biol Chem 280:21506-21514.
35. Yu Y-H, Zhang Y, Oelkers P, Sturley SL, Rader DJ, Ginsberg HN. 2002. Post-transcriptional control of the expression and function of diacylglycerol acyltransferase-1 in mouse adipocytes. J Biol Chem 277:50876-50884.